Prediction of Dry Powder Inhaler Formulation Performance From Surface Energetics and Blending Dynamics

REFERENCES

• N. M. Ahfat, G. Buckton, R. Burrows, and M. D. Ticehurst. (2000). An exploration of inter-relationships between contact angle, inverse phase gas chromatography and triboelectric charging data. Eur. J. Pharm. Sci. 9 (3):271–276.
   PubMed Web of Science ®Google Scholar
• P. Begat, D. A. Morton, J. N. Staniforth, and R. Price. (2004). The cohesive-adhesive balances in dry powder inhaler formulations II: Influence on fine particle delivery characteristics. Pharm. Res. 21 (10):1826–1833.
   PubMed Web of Science ®Google Scholar
• V. Bérard, E. Lesniewska, C. Andrès, D. Pertuy, C. Laroche, and Y. Pourcelot. (2002). Affinity scale between a carrier and a drug in DPI studied by atomic force microscopy. Int. J. Pharm. 247 (1–2):127–137.
   PubMed Web of Science ®Google Scholar
• D. Cline, and R. Dalby. (2002). Predicting the quality of powders for inhalation from surface energy and area. Pharm. Res. 19 (9):1274–1277.
   PubMed Web of Science ®Google Scholar
• J. R. Conder, and C. L. Young. Physicochemical measurement by gas chromatography. Wiley, Chichester, NY, (1979).
   Google Scholar
• M. R. Feddah, K. F. Brown, E. M. Gipps, and N. M. Davies. (2000). In-vitro characterisation of metered dose inhaler verus dry powder inhaler glucocorticoid products: Influence of respiratory flow rates. J. Pharm. Sci. 3 (3):317–324.
   Web of Science ®Google Scholar
• M. Gupta, and N. Bhargava. (2006). Development and validation of a high-performance liquid chromatographic method for analysis of budesonide. J. Pharm. Biomed. Anal. 40:423–428.
   PubMed Web of Science ®Google Scholar
• V. Gutmann. The donor-acceptor approach to molecular interactions. Plenum Press, New York, (1978).
   Google Scholar
• A. J. Hickey. (2003). Pharmaceutical inhalation aerosol powder dispersion––an unbalancing act. Am. Pharm. Rev. 6 (4):106–110.
   Google Scholar
• A. J. Hickey, N. M. Concession, M. Van Oort, and R. M. Platz. (1994). Factors influencing the dispersion of dry powders as aerosols. Pharm. Tech. 8:58–82.
   Google Scholar
• A. J. Hickey, H. M. Mansour, M. J. Telko, Z. Xu, H. D. Smyth, T. Mulder, R. McLean, J. Langridge, and D. Papadopoulos. (2007). Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristics. J. Pharm. Sci. 96 (5):1282–1301.
   PubMed Web of Science ®Google Scholar
• H. Larhrib, X. M. Zeng, G. P. Martin, C. Marriott, and J. Pritchard. (1999). The use of different grades of lactose as a carrier for aerosolised salbutamol sulphate. Int. J. Pharm. 191 (1):1–14.
   PubMed Web of Science ®Google Scholar
• M. D. Louey, P. Mulvaney, and P. J. Stewart. (2001). Characterisation of adhesional properties of lactose carriers using atomic force microscopy. Int. J. Pharm. 25 (3–4):559–567.
   Google Scholar
• M. D. Louey, M. Van Oort, and A. J. Hickey. (2004). Aerosol dispersion of respirable particles in narrow size distributions using drug-alone and lactose-blend formulations. Pharm. Res. 21 (7):1207–1213.
   PubMed Web of Science ®Google Scholar
• H. A. H. Mohammad, and J. T. Fell. (1983). The wetting and dissolution rate of phenobarbitone powders. Drug Dev. Ind. Pharm. 9 (1–2):203–214.
   Web of Science ®Google Scholar
• H. E. Newell, G. Buckton, D. A. Butler, F. Thielmann, and D. R. Williams. (2001a). The use of inverse phase gas chromatography to measure the surface energy of crystalline, amorphous, and recently milled lactose. Pharm. Res. 18 (5):662–666.
   PubMed Web of Science ®Google Scholar
• H. E. Newell, G. Buckton, D. A. Butler, F. Thielmann, and D. R. Williams. (2001b). The use of inverse phase gas chromatography to study the change of surface energy of amorphous lactose as a function of relative humidity and the processes of collapse and crystallisation. Int. J. Pharm. 217 (1–2):45–56.
   PubMed Web of Science ®Google Scholar
• O. Planinsek, J. Zadnik, S. Rozman, M. Kunaver, R. Dreu, and S. Srcic. (2003). Influence of inverse gas chromatography measurement conditions on surface energy parameters of lactose monohydrate. Int. J. Pharm. 256 (1–2):17–23.
   PubMed Web of Science ®Google Scholar
• H. Schiavone, S. Palakodaty, A. Clark, P. York, and S. T. Tzannis. (2004). Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhalers. Int. J. Pharm. 281 (1–2):55–66.
   PubMed Web of Science ®Google Scholar
• J. Schultz, L. Lavielle, and C. Martin. (1987). The role of the interface in carbon fibre-epoxy composites. J. Adhesion 23:45–60.
   Web of Science ®Google Scholar
• B. Y. Shekunov, J. C. Feeley, A. H. L. Chow, H. H. Y. Tong, and P. York. (2003). Aerosolisation behaviour of micronised and supercritically-processed powders. J. Aer. Sci. 34 (5):553–568.
   Web of Science ®Google Scholar
• R. J. Smith, J. K. Haken, and M. S. Wainwright. (1978). Evaluation of mathematical procedures for the calculation of dead-time. J. Chromatogr. 147:65–73.
   Web of Science ®Google Scholar
• H. D. C. Smyth, and A. J. Hickey. (2005). Carriers in drug powder delivery: Implications for inhalation system design. Am. J. Drug Deliv. 3 (2):117–132.
   Google Scholar
• M. J. Telko, and A. J. Hickey. (2007). Critical assessment of inverse gas chromatography as means of assessing surface free energy and acid-base interaction of pharmaceutical powders. J. Pharm. Sci. 96 (10):2647–2654.
   PubMed Web of Science ®Google Scholar
• M. D. Ticehurst, P. York, R. C. Rowe, and S. K. Dwivedi. (1996). Characetrisation of the surface properties of α-lactose monohydrate with inverse gas chromatography, used to detect batch variation. Int. J. Pharm. 141 (1–2):199–206.
   Google Scholar